DAV-210

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDAV-210
Drug Alias NameDAV-210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase modulators
TargetsBeta Lactamase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDa Volterra
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDa Volterra
Active IndicationsN/A
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A